132 related articles for article (PubMed ID: 16651286)
1. The safety of trivalent influenza vaccine among healthy children 6 to 24 months of age.
Goodman MJ; Nordin JD; Harper P; Defor T; Zhou X
Pediatrics; 2006 May; 117(5):e821-6. PubMed ID: 16651286
[TBL] [Abstract][Full Text] [Related]
2. Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003.
McMahon AW; Iskander J; Haber P; Chang S; Woo EJ; Braun MM; Ball R
Pediatrics; 2005 Feb; 115(2):453-60. PubMed ID: 15687455
[TBL] [Abstract][Full Text] [Related]
3. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
[TBL] [Abstract][Full Text] [Related]
4. Serious adverse events rarely reported after trivalent inactivated influenza vaccine (TIV) in children 6-23 months of age.
Rosenberg M; Sparks R; McMahon A; Iskander J; Campbell JD; Edwards KM
Vaccine; 2009 Jul; 27(32):4278-83. PubMed ID: 19450636
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children.
Neuzil KM; Jackson LA; Nelson J; Klimov A; Cox N; Bridges CB; Dunn J; DeStefano F; Shay D
J Infect Dis; 2006 Oct; 194(8):1032-9. PubMed ID: 16991077
[TBL] [Abstract][Full Text] [Related]
6. Safety and tolerability of cold-adapted influenza vaccine, trivalent, in infants younger than 6 months of age.
Vesikari T; Karvonen A; Smith HM; Dunning A; Razmpour A; Saville MK; Gruber WC; Forrest BD
Pediatrics; 2008 Mar; 121(3):e568-73. PubMed ID: 18299305
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6-59 months.
King JC; Cox MM; Reisinger K; Hedrick J; Graham I; Patriarca P
Vaccine; 2009 Nov; 27(47):6589-94. PubMed ID: 19716456
[TBL] [Abstract][Full Text] [Related]
8. A comparison of 2 influenza vaccine schedules in 6- to 23-month-old children.
Englund JA; Walter EB; Fairchok MP; Monto AS; Neuzil KM
Pediatrics; 2005 Apr; 115(4):1039-47. PubMed ID: 15805382
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ
Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851
[TBL] [Abstract][Full Text] [Related]
10. Trivalent inactivated influenza virus vaccine given to two-month-old children: an off-season pilot study.
Walter EB; Englund JA; Blatter M; Nyberg J; Ruben FL; Decker MD;
Pediatr Infect Dis J; 2009 Dec; 28(12):1099-104. PubMed ID: 19935270
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B;
Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of inactivated influenza vaccine in children less than 5 years of age over multiple influenza seasons: a case-control study.
Joshi AY; Iyer VN; St Sauver JL; Jacobson RM; Boyce TG
Vaccine; 2009 Jul; 27(33):4457-61. PubMed ID: 19490957
[TBL] [Abstract][Full Text] [Related]
13. Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents.
Bergen R; Black S; Shinefield H; Lewis E; Ray P; Hansen J; Walker R; Hessel C; Cordova J; Mendelman PM
Pediatr Infect Dis J; 2004 Feb; 23(2):138-44. PubMed ID: 14872180
[TBL] [Abstract][Full Text] [Related]
14. Impact of influenza on young children and the shaping of United States influenza vaccine policy.
Terebuh P; Uyeki T; Fukuda K
Pediatr Infect Dis J; 2003 Oct; 22(10 Suppl):S231-5. PubMed ID: 14551482
[TBL] [Abstract][Full Text] [Related]
15. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.
Ashkenazi S; Vertruyen A; Arístegui J; Esposito S; McKeith DD; Klemola T; Biolek J; Kühr J; Bujnowski T; Desgrandchamps D; Cheng SM; Skinner J; Gruber WC; Forrest BD;
Pediatr Infect Dis J; 2006 Oct; 25(10):870-9. PubMed ID: 17006279
[TBL] [Abstract][Full Text] [Related]
16. Implementation of universal influenza immunization recommendations for healthy young children: results of a randomized, controlled trial with registry-based recall.
Kempe A; Daley MF; Barrow J; Allred N; Hester N; Beaty BL; Crane LA; Pearson K; Berman S
Pediatrics; 2005 Jan; 115(1):146-54. PubMed ID: 15629993
[TBL] [Abstract][Full Text] [Related]
17. Influenza vaccination coverage of children aged 6 to 23 months: the 2002-2003 and 2003-2004 influenza seasons.
Santibanez TA; Santoli JM; Bridges CB; Euler GL
Pediatrics; 2006 Sep; 118(3):1167-75. PubMed ID: 16951012
[TBL] [Abstract][Full Text] [Related]
18. Safety of the trivalent inactivated influenza vaccine among children: a population-based study.
France EK; Glanz JM; Xu S; Davis RL; Black SB; Shinefield HR; Zangwill KM; Marcy SM; Mullooly JP; Jackson LA; Chen R
Arch Pediatr Adolesc Med; 2004 Nov; 158(11):1031-6. PubMed ID: 15520339
[TBL] [Abstract][Full Text] [Related]
19. Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the vaccine safety datalink.
Glanz JM; Newcomer SR; Hambidge SJ; Daley MF; Narwaney KJ; Xu S; Lee GM; Baggs J; Klein NP; Nordin JD; Naleway AL; Belongia EA; Weintraub ES
Arch Pediatr Adolesc Med; 2011 Aug; 165(8):749-55. PubMed ID: 21810637
[TBL] [Abstract][Full Text] [Related]
20. Compliance with the recommendations for 2 doses of trivalent inactivated influenza vaccine in children less than 9 years of age receiving influenza vaccine for the first time: a Vaccine Safety Datalink study.
Jackson LA; Neuzil KM; Baggs J; Davis RL; Black S; Yamasaki KM; Belongia E; Zangwill KM; Mullooly J; Nordin J; Marcy SM; DeStefano F
Pediatrics; 2006 Nov; 118(5):2032-7. PubMed ID: 17079576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
